// App-Quantinova.ai

AB0755 : REAL WORLD EFFECTIVENESS OF SECUKINUMAB IN PSORIATIC ARTHRITIS: FINDINGS FROM A RECENT CROSS SECTIONAL SURVEY OF RHEUMATOLOGISTS AND PATIENTS IN EUROPE

Researchers

Presenter

  • P. G. Conaghan

Principal Investigators

  • E. Holdsworth

  • H. Tian

  • N. Booth

  • P. Anthony

  • N. Modi

  • D. Keininger

  • U. Kiltz

Medical Centers

  • University of Leeds, Leeds, United Kingdom

  • Adelphi Real World, Bollington, United Kingdom

  • Novartis Pharmaceuticals Corporation East Hanover NJ United States

  • Novartis Healthcare Pvt. Ltd, Hyderabad, India

  • Novartis AG, Basel, Switzerland

  • Rheumatology Department, Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Bochum, Germany

Locations

  • United Kingdom

  • United States

  • India

  • Switzerland

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Musculoskeletal

  • Autoimmune (AI)

Disease

  • Psoriatic arthritis

  • Psoriasis

Biomarkers

  • N/A

Drug/Treatment

  • secukinumab

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved